BioCentury
ARTICLE | Company News

AltaRex, Epigen to enter cancer deal

June 6, 2001 7:00 AM UTC

AltaRex (TSE:AXO) and Epigen (Rochester, N.Y.) will develop antibody therapeutics for cancers associated with Epigen's human carcinoma antigen (HCA), which the companies said is associated with the ma...